Comparison of the epidemiology, profile of mutations, and clinical response to antiretrovirals among subtypes B and F of the human immunodeficiency virus type 1

Memorias do Instituto Oswaldo Cruz

Volumn 102, Issue 6, 2007, Pages 693-699

  Lacerda, Heloisa Ramos ^a,b   De Medeiros, Luzidalva Barbosa ^b   Cavalcanti, Ana Maria Salustiano ^c   Ximenes, Ricardo Arraes De Alencar ^a   De Albuquerque, Maria De Fátima Pessoa Militão ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c Secretaria Estadual de Saude de Pernambuco   (Brazil)

Author keywords

Antiretroviral therapy; Genotyping; Human immunodeficiency virus type 1; Subtypes

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 36348955589     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762007000600006     Document Type: Article

References (35)

1. Accetturi CA, Pardini R, Novaes Pinto GH, Turcato G Jr, Lewi DS, Diaz RS 2000. Effects of CCR5 genetic polymorphism and HIV-1 subtype in antiretroviral response in Brazilian HIV-1-infected patients. J Acquir Immune Defic Syndr 24: 399-400.
2. Apetrei C, Marx PA, Smith SM 2004. The evolution of HIV and its consequences. Infect Dis Clin N Am 18: 369-394.
3. Atlas A, Granath F, Lindstrom A, Lidman K, Lindback S, Alaeus A 2005. Impact of HIV type 1 genetic subtype on the outcome of antiretroviral therapy. AIDS Res Hum Retroviruses 21: 221-227.
4. Avilla MM, Pando MA, Carrion G, Salomon H, Carrillo MG, Sanchez J, Maulen S, Hierholzer J, Marinello M, Negrete M, Russel KL, Carr JK 2002. Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr 29: 422-426.
5. Barreto CC, Nishyia A, Araujo LV, Ferreira JE, Bush MP, Sabino EC 2006. Trends in antiretroviral drug resistance and clade distributions among HIV-1 infected blood donors in São Paulo, Brazil. J Acquir Immune Defic Syndr 41: 338-341.
6. Bello G, Guimarães ML, Morgado MG 2006. Evolutionary history of HIV-1 subtype B and F infection in Brazil. AIDS 20: 763-768.
7. Bocket L, Cheret A, Deuffic-Burban S, Choisy P, Gerard Y, de la Tribonniere X, Viget N, Ajana F, Goffard A, Barin F, Mouton Y, Yazdanpanah Y 2005. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness. Antivir Ther 10: 247-254.
8. Brazilian Ministry of Health 2002. Consensus for the treatment of adults and adolescents with HIV infection. National Program of STD/AIDS, Brasília, 120 pp.
9. a Semana Epidemiológica, janeiro -junho.
10. Brindeiro R, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, Dantas MC, Barreira D, Teixeira PR, Tanuri A and the Brazilian Network for Drug Resistence Surveillance 2003. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS 17: 1063-1069.
11. Brito AM, Castilho EA, Szwarchwald CL 2005. Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy. Braz J Infect Dis 9: 9-19.
12. Cerqueira DM, Amorim RM, Silva RR, Camara GN, Brigido MM, Martins CR 2004. Antiretroviral resistance and genetic diversity of human immunodeficiency vírus type 1 isolates from the Federal District, Central Brazil. Mem Inst Oswaldo Cruz 99: 877-882.
13. Couto-Fernandes JC, Silva-de-Jesus C, Veloso VG, Rachid M, Gracie RSG, Chequer-Fernandez SL, Oliveira SM, Arakaki-Sanchez D, Chequer PJN, Morgado MG 2005. Human immunodeficiency vírus type 1 genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutaions in HIV-1 infected individuals failing highly active antiretroviral therapy. Mem Inst Oswaldo Cruz 100: 73-78.
14. D'Aquilla RT, Shapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzes DR, Loveday C, Shafer RW, Richmann DD, International AIDS Society-USA 2002. Drug resistance mutations in HIV-1. Top HIV Med 10: 21-25.
15. Essex M, Soto-Rodrigues LE, Renjifo E, Wang WK, Lee TH 1997. Genetic variation within human immunodeficiency viruses generates rapid changes in tropism, virulence, and transmission. Leukemia 11: S93-S94.
16. Fleury HJ, Toni TA, Lan NTH, Hung PV, Deshpande A, Recordon-Pinson P, Boucher S, Lazaro E, Jauvin V, Lavignolle-Aurillac V, Lebel-binay S, Cheret A, Masquelier B 2005. Susceptibility to ARV's of CRF01_AE, CRF02_AG and subtype C viruses from naïve patients: comparative genotypical and phenotypical data. Antivir Ther 10: S148.
17. Frater J 2002. The impact of HIV-1 subtype on the clinical response on HAART. J HIV Ther 7: 92-96.
18. Frater AJ, Beardall A, Ariyoshi K, Churchill D, Galpin S, Clark JR 2001. Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1 infected African patients. AIDS 15: 1493-1502.
19. Frater AJ, Dunn DT, Beardall AJ, Ariyoshi K, Clarke JR, McClure MO 2002. Comparative response of African HIV-1 infected individuals to highly active antiretroviral therapy. AIDS 16: 1139-1146.
20. Geretti AM 2006. HIV-1 subtypes: epidemiology and significance for HIV management. Curr Opin Infect Dis 19: 1-7.
21. Holquin A, Ramirez de Arellano E, Rivas P, Soriano V 2006. Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes. AIDS Rev 8: 98-107.
22. Kantor R, Katzenstein DA, Efron B et al. 2005. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. Plos Medicine 2: 325-336.
23. Kuiken C, Korber B, Shafer RW 2003. HIV sequence databases. AIDS Rev 5: 52-61.
24. Masciotra S, Livellara B, Belloso W, Clara L, Tanuri A, Ramos AC, Baggs J, Lal R, Pieniazek D 2000. Evidence of a high frequency of HIV-1 subtype F infections in heterosexual population in Buenos Aires, Argentina. AIDS Res Hum Retroviruses 16: 1007-1014.
25. Montano SM, Sanchez JL, Laguna-Torres A et al. 2005. Prevalences, genotypes, and risk factors for HIV transmission in South America. J Acquir Immune Defic Syndr 40: 57-64.
26. Pinto ME, Struchiner CJ 2006. HIV-1 diversity: a tool for studying the pandemic. Reports in Public Health 22: 473-484.
27. Pires IL, Soares MA, Speranza FA, Ishii SK, Vieira MCG, Gouvêa MIFS, Guimarães MAAM, Oliveira FE, Magnanini MMF, Brindeiro RM, Tanuri A 2004. Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naïve, infected individuals in the Army Health Service of Rio de Janeiro, Brazil. J Clin Microbiol 42: 426-430.
28. Rios M, Fernandez J, Jaramillo P, Paredes V, Sanchez JL, Laguna-Torres VA, Carr JK, Ramirez E 2005. Molecular epidemiology of HIV type 1 in Chile: differential geographic and transmission route distribution of B and F subtypes. AIDS Res Hum Retroviruses 21: 835-840.
29. Rodrigues R, Vazquez CMP, Colares JK, Custodio RM, Bonasser Filho F, Souza LR, Gianna MC, Marques CCA, Brigido LFM 2005. Antiretroviral resistance mutations in human immunodeficiency vírus type 1 infected patients enrolled in genotype testing at the Central Public Health Laboratory, São Paulo, Brazil: preliminary results. Mem Inst Oswaldo Cruz 100: 97-102.
30. Soares EAJM, Santos RP, Pellegrini JA, Sprinz E, Tanuri A, Soares M 2003. Epidemiologic and molecular characterization of human immunodeficiency virus type 1 in Southern Brazil. J Acquir Immune Defic Syndr 34: 520-526.
31. Solis M, Wilkinson P, Romieu R, Hernandez E, Wainberg MA, Hiscott J 2006. Gene expression profiling of the host response to HIV-1 B, C or A/E infection in monocyte-derived dendritic cells. Virology 352: 86-99.
32. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R 1996. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 271: 1291-1293.
33. Stanford University HIV drug resistance database. Available at http://hivdb.stanford.edu/; cited 18 november 2006.
34. Tanuri A, Vicente AC, Otsuki K, Ferreira OC, Schechter M, Janini LM, Pieniazek D, Rayfield MA 1999. Genetic variation and susceptibilities to protease inhibitors among subtypes B and F isolates in Brazil. Antimicrob Agents Chemother 43: 253-258.
35. Thompson MM, Pérez-Álvarez L, Nájera R 2002. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2: 461-471.